These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19756346)

  • 1. Association of IL-15 polymorphisms with bone mineral density in postmenopausal Korean women.
    Koh JM; Oh B; Ha MH; Cho KW; Lee JY; Park BL; Shin HD; Bae MA; Kim HJ; Hong JM; Kim TH; Shin HI; Lee SH; Kim GS; Kim SY; Park EK
    Calcif Tissue Int; 2009 Nov; 85(5):369-78. PubMed ID: 19756346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms and haplotypes of integrinalpha1 (ITGA1) are associated with bone mineral density and fracture risk in postmenopausal Koreans.
    Lee HJ; Kim SY; Koh JM; Bok J; Kim KJ; Kim KS; Park MH; Shin HD; Park BL; Kim TH; Hong JM; Park EK; Kim DJ; Oh B; Kimm K; Kim GS; Lee JY
    Bone; 2007 Dec; 41(6):979-86. PubMed ID: 17931993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women.
    Koh JM; Oh B; Lee JY; Lee JK; Kimm K; Park BL; Shin HD; Lee IK; Kim HJ; Hong JM; Kim TH; Kim GS; Kim SY; Park EK
    J Bone Miner Res; 2007 Nov; 22(11):1752-8. PubMed ID: 17620055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women.
    Czerny B; Kaminski A; Kurzawski M; Kotrych D; Safranow K; Dziedziejko V; Bohatyrewicz A; Pawlik A
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):82-5. PubMed ID: 20060205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort.
    Agueda L; Urreizti R; Bustamante M; Jurado S; Garcia-Giralt N; Díez-Pérez A; Nogués X; Mellibovsky L; Grinberg D; Balcells S
    Calcif Tissue Int; 2010 Jul; 87(1):14-24. PubMed ID: 20390408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
    Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
    Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
    Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis.
    Ioannidis JP; Stavrou I; Trikalinos TA; Zois C; Brandi ML; Gennari L; Albagha O; Ralston SH; Tsatsoulis A;
    J Bone Miner Res; 2002 Nov; 17(11):2048-60. PubMed ID: 12412813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women.
    Kim JG; Choi YM; Moon SY; Lee JY
    Menopause; 2003; 10(6):544-9. PubMed ID: 14627864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the CLCN7 gene are associated with BMD in women.
    Pettersson U; Albagha OM; Mirolo M; Taranta A; Frattini A; McGuigan FE; Vezzoni P; Teti A; van Hul W; Reid DM; Villa A; Ralston SH
    J Bone Miner Res; 2005 Nov; 20(11):1960-7. PubMed ID: 16234969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women.
    Lee HJ; Koh JM; Hwang JY; Choi KY; Lee SH; Park EK; Kim TH; Han BG; Kim GS; Kim SY; Lee JY
    Calcif Tissue Int; 2009 Jun; 84(6):439-45. PubMed ID: 19424741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland.
    Giraudeau FS; McGinnis RE; Gray IC; O'Brien EJ; Doncaster KE; Spurr NK; Ralston SH; Reid DM; Wood J
    J Bone Miner Res; 2004 Jan; 19(1):31-41. PubMed ID: 14753734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
    Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ;
    Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of SMAD2 polymorphisms with bone mineral density in postmenopausal Korean women.
    Kim BJ; Hwang JY; Han BG; Lee JY; Lee JY; Park EK; Lee SH; Chung YE; Kim GS; Kim SY; Koh JM
    Osteoporos Int; 2011 Aug; 22(8):2273-82. PubMed ID: 21052639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.